Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Corvex Signs $103M Three-Year NVIDIA Blackwell GPU Deal

Corvex, Inc. filed a Form 8-K with the SEC on November 16, 2026, disclosing that it entered into a definitive three-year, $103 million take-or-pay agreement to provide NVIDIA Blackwell computing capacity to a scaled AI inference platform.

Manish Choudhary | 16 November 2026

Akebia Therapeutics Enters $140M Symbiotic Term Loan

Akebia Therapeutics, Inc. filed a Form 8-K on November 16, 2026, disclosing that on November 12, 2026, the company entered into a senior secured term loan facility of up to $140.0 million with Symbiotic Capital Opportunities Holding, L.P. as lender and Symbiotic Capital Agency …

Vinay Lochav | 16 November 2026

LKQ Names Paul Shaw President of North America Segment

LKQ Corporation filed an 8-K with the SEC on November 16, 2026, disclosing that Senior Vice President and North America segment President John Meyne announced his retirement effective December 31, 2026, and that Paul Shaw has been appointed to succeed him beginning January 1, …

Nitish Kishor | 16 November 2026

News Corporation Reports ASX Buyback Disclosures, Nov 12

News Corporation filed a Form 8-K on November 16, 2026, reporting the attachment of four exhibits containing share repurchase transaction information provided to the Australian Securities Exchange on dates noted within those exhibits, in connection with the company's ongoing stock repurchase program.

Vinay Lochav | 16 November 2026

CG Oncology PIVOT-006 Phase 3 Shows 68% Recurrence Risk Cut

CG Oncology, Inc. filed a Form 8-K on November 16, 2026, disclosing topline data from its Phase 3 PIVOT-006 registrational trial of cretostimogene in intermediate-risk and high-grade Ta non-muscle invasive bladder cancer, along with updated BLA submission timelines.

Shwetambri Chauhan | 16 November 2026

Everforth Plans $500M Senior Notes Offering Due 2031

Everforth, Inc. filed a Form 8-K with the SEC on November 16, 2026, disclosing its intention to commence a private offering of $500 million aggregate principal amount of unsecured senior notes due 2031.

Aakashdeep | 16 November 2026

Cadre Holdings CFO Blaine Browers Resigns, Chad Appleby Named Interim

Cadre Holdings, Inc. filed a Form 8-K on November 16, 2026, disclosing that Chief Financial Officer Blaine Browers has resigned effective December 31, 2026, and that Chad Appleby has been appointed interim CFO beginning that same date.

Aditi Sarkar | 16 November 2026

WidePoint Files Q3 2026 Earnings Results Form 8-K

WidePoint Corporation filed a Current Report on Form 8-K on November 16, 2026, disclosing that it conducted an earnings conference call and issued a press release on November 12, 2026, covering financial results for the quarter and nine-month periods ended September 30, 2026.

Manish Choudhary | 16 November 2026

Arcturus Therapeutics Sells 2,466,395 Shares to Meiji for $50M

Arcturus Therapeutics Holdings Inc. filed a Form 8-K on November 16, 2026, disclosing a $50.0 million stock sale to Meiji Seika Pharma Co., Ltd. and concurrent collaboration agreements, including a license and a non-binding memorandum of understanding.

Vinay Lochav | 16 November 2026

Iroquois Files Amendment 6 on Clearmind Medicine Warrants

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page filed Amendment No. 6 to a Schedule 13G with the SEC on November 16, 2026, disclosing beneficial ownership of Common Shares of Clearmind Medicine Inc. as of September 30, 2026.

Shwetambri Chauhan | 16 November 2026
Support

Hi! How can we help you today?

Loading…